Bioactivity:

Eflucimibe is an ACAT inhibitor. Eflucimibe regulates endogenous hypercholesterolemia in a synergistic manner in New Zealand rabbits fed a casein-enriched diet. In vivo, orally administered Eflucimibe displayed high potency and efficacy as an antihypercho

CAS nr:

202340-45-2

Purity:

98%

Molecular Weight:

469,73

SMILES:

O=C(NC1=CC(C)=C(O)C(C)=C1C)[C@@H](SCCCCCCCCCCCC)C2=CC=CC=C2

Formula:

C29H43NO2S

Pathway:

Target: